GONADOTROPIN-RELEASING-HORMONE AGONIST PLUS ADD-BACK SEX STEROIDS TO REDUCE RISK OF BREAST-CANCER

被引：1

|

作者：

SPICER, D

SHOUPE, D

PIKE, M

机构：

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1991年 / 83卷 / 23期

关键词：

D O I：

10.1093/jnci/83.23.1763

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1763 / 1763

页数：1

相关论文

共 50 条

[1] EFFECT OF GONADOTROPIN-RELEASING-HORMONE AGONIST (GNRHA) PLUS ADD-BACK SEX-STEROIDS ON BONE-DENSITY IN PREMENOPAUSAL WOMEN
RUDE, RK
SPICER, DV
PIKE, A
PIKE, MC
JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S322 - S322
[2] Chemoprevention for young women at high risk for breast cancer using a gonadotropin releasing hormone agonist (GnRHA) and low-dose add-back sex steroids contraceptive regimen.
Daniels, A
Pike, MC
Spicer, DV
Daniels, JR
Ursin, G
Weitzel, JN
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1161S - 1161S
[3] LONG-TERM GONADOTROPIN-RELEASING-HORMONE AGONIST THERAPY - THE EVOLVING ISSUE OF STEROIDAL ADD-BACK PARADIGMS
ADASHI, EY
HUMAN REPRODUCTION, 1994, 9 (07) : 1380 - 1397
[4] TREATMENT OF BREAST-CANCER WITH GONADOTROPIN-RELEASING-HORMONE
MANNI, A
SANTEN, R
HARVEY, H
LIPTON, A
MAX, D
ENDOCRINE REVIEWS, 1986, 7 (01) : 89 - 94
[5] A PROSPECTIVE, RANDOMIZED TRIAL OF GONADOTROPIN-RELEASING-HORMONE AGONIST PLUS ESTROGEN-PROGESTIN OR PROGESTIN ADD-BACK REGIMENS FOR WOMEN WITH LEIOMYOMATA UTERI
FRIEDMAN, AJ
DALY, M
JUNEAUNORCROSS, M
REIN, MS
FINE, C
GLEASON, R
LEBOFF, M
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (06): : 1439 - 1445
[6] Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
Surrey, Eric S.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2010, 22 (04) : 283 - 288
[7] The need for add-back with gonadotrophin-releasing hormone agonist therapy
Studd, J
Leather, AT
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 : 1 - 4
[8] STEROIDAL AND NONSTEROIDAL ADD-BACK THERAPY - EXTENDING SAFETY AND EFFICACY OF GONADOTROPIN-RELEASING-HORMONE AGONISTS IN THE GYNECOLOGIC PATIENT
SURREY, ES
FERTILITY AND STERILITY, 1995, 64 (04) : 673 - 685
[9] A POSSIBLE DIRECT ACTION OF A GONADOTROPIN-RELEASING-HORMONE AGONIST, GOSERELIN, ON THE CLONOGENIC GROWTH OF HUMAN BREAST-CANCER
NOMURA, Y
TASHIRO, H
HISAMATSU, K
ANTICANCER RESEARCH, 1993, 13 (5A) : 1443 - 1446
[10] Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and ''add-back'' therapy
Murray, SC
Muse, KN
FERTILITY AND STERILITY, 1997, 67 (02) : 390 - 393

← 1 2 3 4 5 →